phorbolol myristate acetate has been researched along with Triple Negative Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Romero, Y; Wise, R; Zolkiewska, A | 1 |
1 other study(ies) available for phorbolol myristate acetate and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells.
Topics: ADAM10 Protein; ADAM17 Protein; Amyloid Precursor Protein Secretases; B7-H1 Antigen; Cell Line, Tumor; Female; Humans; Ionomycin; Lymphocytes, Tumor-Infiltrating; Lysosomes; Membrane Proteins; Programmed Cell Death 1 Receptor; Proteolysis; Signal Transduction; Tetradecanoylphorbol Acetate; Triple Negative Breast Neoplasms | 2020 |